Photo of Jeffrey Weiss

Jeffrey Weiss

  • ASSOCIATE PROFESSOR Medicine, General Internal Medicine
Print ProfilePrint Profile


Training Areas


  • PHD, Northwestern University

  • A.B., Stanford University
    Psychology (with Distinction)

  • Internship, Clinical Psychology
    Michael Reese Hospital



March 4, 2005 - February 28, 2010

Adherence to HCV Treatment in HCV and HCV/HIV Patients

This is a prospective cohort study in which 100 HCV and 100 HCV/HIV patients will be enrolled just prior to initiating HCV therapy with pegylated IFN-alfa and ribavirin (PEG-IFN/RBV). The patients will be followed for the first 24 weeks of treatment to determine whether depression, neurocognitive functioning, substance abuse and treatment self-efficacy are associated with early treatment discontinuation and whether the two groups differ in rates of early treatment discontinuation.

Keywords: HIV, HCV, Adherence


Weiss JJ, Osorio G, Ryan E, Marcus S, Fishbein D. Prevalence and patient awareness of medical comorbities in an urban AIDS clinic.. AIDS Patient Care & STDs 2010; 24: 39-48.

Weiss JJ, Morgello S. Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: Survey of provider practices.. General Hospital Psychiatry 2009; 31: 531-537.

Weiss JJ, Brau N, Stivala A, Swan T, Fishbein D. Adherence to medication for chronic hepatitis C: Building on the model of human immunodeficiency virus antiretroviral adherence research.. Alimentary Pharmacology & Therapeutics 2009; 30: 14-27.

Weiss JJ, Bhatti L, Dieterich DT, Edlin BR, Fishbein DA, Goetz MB, Yu K, Wagner GJ. Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Alimentary Pharmacology & Therapeutics 2008; 28: 289-293.

Weiss JJ, Bangsberg DR. Comprehensive Textbook of AIDS Psychiatry (2008). In: Cohen MA, Gorman JM, editors. Psychiatric Aspects of Adherence to Medical Care and Treatment in HIV/AIDS
Comprehensive Textbook of AIDS Psychiatry (2008). New York, Oxford University Press; pp281-295.

Hutton HH, Santora PB, Weiss JJ. Addiction Treatment: Science and Policy for the Twenty-first Century (2007). In: Henningfield JE, Santora PB, Bickel WK, editors. Addiction and Multiple Morbidities in HIV-Positive Patients
Addiction Treatment: Science and Policy for the Twenty-first Century (2007). Baltimore, The Johns Hopkins University Press;.

Niego SH, Kofman MD, Weiss JJ, Geliebter A. Binge eating in the bariatric surgery population: A review of the literature. International Journal of Eating Disorders 2007; 40: 349-359.

Weiss JJ, Gorman JM. Psychiatric Behavioral Aspects of Co-management of HCV and HIV. Current HIV/AIDS Reports 2006; 3: 176-181.

Weiss JJ, Gorman JM. Antidepressant adherence and suicide risk in depressed youth [Letter to the editor]. American Journal of Psychiatry 2005; 162: 1756-1757.

Weiss JJ, Mulder CL, Antoni MH, de Vroome EM, Garssen B, Goodkin K. Effects of a supportive-expressive group intervention on long-term psychosocial adjustment in HIV-infected gay men. Psychotherapy and Psychosomatics 2003; 72: 132-140.

Hoffman RG, Cohen MA, Alfonso CA, Weiss JJ, Jones S, Keller M, Condemarin JR, Chiu N, Jacobson JM. Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV. Psychosomatics 2003; 44: 417-420.

Knippels H, Goodkin K, Weiss JJ, Wilkie FL, Antoni MH. The importance of cognitive self-report in early HIV-1 infection: Validation of a cognitive functional status sub-scale. AIDS 2002; 16: 259-267.

Weiss JJ. AIDS in Europe: New Challenges for the Social Sciences (2000). In: Moatti JP, Souteyrand Y, Prieur A, Sandfort T, Aggleton P, editors. Attitudinal factors and adherence to protease inhibitor combination therapy
AIDS in Europe: New Challenges for the Social Sciences (2000). London, Routledge; pp45-56.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Weiss during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • AbbVie Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


17 East 102 Street Floor 6th Room D6-150
New York, NY 10029

Tel: 212-824-7575
Fax: 212-824-2317


One Gustave L. Levy Place
Box 1087
New York, NY 10029

Tel: 212-824-7575
Fax: 212-824-2317